Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Details Narrative)

v3.7.0.1
Basis of Presentation and Significant Accounting Policies (Details Narrative)
3 Months Ended
Mar. 31, 2017
USD ($)
Breathlyzers
Mar. 31, 2016
USD ($)
Dec. 31, 2016
USD ($)
Allowances for doubtful accounts for trade receivables $ 187,055   $ 1,010,196
Bad debt expenses 42,361  
Deferred revenue 28,202 172,776  
Revenue recognition rebates expense 102,824 99,968  
Shipping, handling and transportation costs 18,420 16,045  
Cost of net revenue $ 16,177 $ 21,714  
Product Revenue [Member]      
Concentration risk percentage 67.00%    
Trade Receivable [Member]      
Concentration risk percentage 55.00%    
Concentration risk, number of customer | Breathlyzers 2    
Fulton Bank of New Jersey [Member]      
Cash $ 2,080,924   67,865
Bank of America [Member]      
Cash 118   795
PayPal [Member]      
Cash $ 4,040   $ 4,040
Minimum [Member]      
Normal credit terms extended to customers 30 days    
Maximum [Member]      
Normal credit terms extended to customers 90 days    
Cash, FDIC insured amount $ 250,000    
Maximum [Member] | Patents [Member]      
Finite-lived intangible asset, useful life 17 years